These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5446375)

  • 1. Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues.
    Nybäck H; Sedvall G
    Eur J Pharmacol; 1970 May; 10(2):193-205. PubMed ID: 5446375
    [No Abstract]   [Full Text] [Related]  

  • 2. Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs.
    Nybäck H; Borzecki Z; Sedvall G
    Eur J Pharmacol; 1968 Nov; 4(4):395-403. PubMed ID: 5724916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of 15 neuroleptics (butyrophenones and phenothiazines) on changes in noradrenaline content of the brain and activity of the rat in the self stimulation test].
    Dresse A
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):353-65. PubMed ID: 5916740
    [No Abstract]   [Full Text] [Related]  

  • 4. Regional disappearance of catecholamines formed from 14 C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine.
    Nybäck H
    Acta Pharmacol Toxicol (Copenh); 1971; 30(5):372-84. PubMed ID: 4401187
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of drugs on catecholamine metabolism in brain as studied by 14C-tyrosine.
    Nybäck H; Sedvall G
    Br J Pharmacol; 1968 Sep; 34(1):220P-221P. PubMed ID: 5676022
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between the lipophilic nature of tricyclic neuroleptics and antidepressants, and histamine release.
    Frisk-Holmberg M; van der Kleijn E
    Eur J Pharmacol; 1972 May; 18(2):139-47. PubMed ID: 4113999
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonistic effect of phenothiazine derivatives on nicotine-induced death in mice.
    Yamamoto I; Inoki R; Iwatsubo K
    Jpn J Pharmacol; 1967 Mar; 17(1):133-4. PubMed ID: 5299967
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain.
    Nybäck H; Sedvall G
    J Pharmacol Exp Ther; 1968 Aug; 162(2):294-301. PubMed ID: 5666984
    [No Abstract]   [Full Text] [Related]  

  • 9. Acceleration of turnover of 14C-catecholamines in rat brain by chlorpromazine.
    Gey KF; Pletscher A
    Experientia; 1968 Apr; 24(4):335-6. PubMed ID: 5705176
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of chlorpromazine and some of its metabolites on synthesis and turnover of catecholamines formed from 14 C-tyrosine in mouse brain.
    Nybäck H; Sedvall G
    Psychopharmacologia; 1972; 26(2):155-60. PubMed ID: 5073041
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of brain lesions and chlorpromazine on accumulation and disappearance of catecholamines formed in vivo from 14 C-tyrosine.
    Nybäck H
    Acta Physiol Scand; 1972 Jan; 84(1):54-64. PubMed ID: 5029384
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. 3. Inhibition kinetics with highly purified D-amino acid oxidase.
    Gabay S; Harris SR
    Biochem Pharmacol; 1967 May; 16(5):803-12. PubMed ID: 4382519
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects on mouse brain catecholamine turnover of chlorpromazine, trifluoperazine and closely-related non-tranquillizing analogues.
    Green AL
    J Pharm Pharmacol; 1973 Mar; 25(3):267-9. PubMed ID: 4146333
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional accumulation of catecholamines formed from tyrosine-14C in rat brain: effect of chlorpromazine.
    Nybäck H; Sedvall G
    Eur J Pharmacol; 1969 Feb; 5(3):245-52. PubMed ID: 5772674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of various neuroleptics after single repeated treatment in the mice submitted to the four plate test and the escape test].
    Gouret C; Raynaud G
    C R Seances Soc Biol Fil; 1974; 168(2-3):270-5. PubMed ID: 4156656
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
    Stille G
    Schweiz Med Wochenschr; 1969 Nov; 99(46):1645-52 contd. PubMed ID: 4391348
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of chlorpromazine on catecholamine synthesis in rat and mouse brain.
    Nybäck H; Sedvall G
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:23-4. PubMed ID: 5630930
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of phenothiazines and phenothiazine metabolites on adenyl cyclase and the cyclic AMP response in the rat brain.
    Palmer GC; Manian AA
    Adv Biochem Psychopharmacol; 1974; 9(0):749-67. PubMed ID: 4365287
    [No Abstract]   [Full Text] [Related]  

  • 19. Norepinephrine and dopamine in the corpus striatum and remainder of the brain following phenothiazine treatment.
    Angelakos ET; McKenna OC
    Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):288-92. PubMed ID: 5895686
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between gastric secretory inhibition and cerebral and gastric levels of monoamines in pylorus-ligated rats.
    Yamaguchi I; Katsuki S; Oashi T; Kumada S
    Jpn J Pharmacol; 1973 Aug; 23(4):523-34. PubMed ID: 4543251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.